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Sara Ramos-Romero1, Francisco J. Pérez-Cano1,2, Cristina Castellote1,2,3, Margarida Castell1,2*
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Abstract
Cocoa and its flavonoids have potential anti-inflammatory properties in vitro and in acute inflammation models in vivo. The aim of the
present study was to ascertain the effects of two cocoa-enriched diets on adjuvant arthritis (AA) in rats, considering not only clinical
and biochemical inflammatory indices, but also antibody response and lymphocyte composition. Female Wistar rats were fed with a 5
or 10 % cocoa-enriched diet beginning 2 weeks before arthritis induction and until the end of the study. AA was induced by an intradermal
injection of heat-killed Mycobacterium butyricum suspension. The hind-paw swelling (plethysmometry), serum anti-mycobacterial anti-
body concentration (ELISA), blood and inguinal lymph node lymphocyte subset percentage (flow cytometry), and IL-2, interferon g
and PGE2 released from splenocytes (ELISA) were assessed. Although the cocoa diets had no significant effect on hind-paw swelling,
a tendency to reduce it was observed at the end of the study. Cocoa-enriched diets were able to decrease the serum anti-mycobacterial
antibody concentration and the splenocyte PGE2 production, as well as the proportion of T-helper (Th) lymphocytes in blood and regional
lymph nodes, which probably includes cells responsible for the arthritic process. The cocoa diets prevented a decrease in the proportion
of regulatory T-cells in blood and a disequilibrium between inguinal lymph node natural killer (NK) CD8þ and NK CD82 subsets.
In conclusion, the cocoa-enriched diets during AA were not able to significantly decrease joint inflammation but modified Th-cell
proportions and prevented specific antibody synthesis.
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In ancient civilisations, cocoa (Theobroma cacao seed
product) used to be consumed for its beneficial effects on
health(1–3), but it changed from being consumed for medi-
cinal purposes to being eaten as a confectionery in modern
society. Nowadays, there is a resurgence of interest in the
health properties of cocoa and its derivatives. Much scien-
tific evidence has suggested that the beneficial effects of
cocoa are associated with its flavonoids(4). Cocoa mainly con-
tains flavan-3-ols such as (2)-epicatechin and (þ)-catechin
(0·20–3·50 mg/g), and their polymers called proanthocya-
nidins (2·16–100 mg/g)(5,6), which, unlike other products
such as tea, apples, grapes or red wine, can have up to ten
linked units of flavanol monomers(7). Large proanthocyanidins
are less efficiently absorbed in the small intestine than shorter
flavanols, and as a result they reach to the colon, where they
are transformed by intestinal microbiota and absorbed
through the intestinal barrier(8). In consequence, the beneficial
effect of these phytochemicals could be mainly attributed
to metabolites derived from the microbial catabolism of
proanthocyanidins(9,10). Large proanthocyanidins in the colon
may have an important local function neutralising oxidants
and carcinogenic compounds all along the gut(11). On the
other hand, in addition to flavanols, quercetin and its deri-
vatives, such as quercitrin, isoquecitrin, rutin, naringenin,
luteolin and apigenin, are also present in cocoa in smaller
quantities(12).
Despite some in vitro studies, the influence of cocoa on
the immune system is still relatively unknown. Previously,
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we reported that a cocoa-enriched diet modifies lymphocyte
composition and function in several lymphoid tissues in
rats(13,14). Specifically, a 10 % cocoa diet given to young rats
over 3 weeks increases the proportion of B-cells in the
spleen(13), mesenteric lymph nodes and also in Peyer’s
patches(14), whereas it down-regulates serum IgG, IgM and
IgA production(13). Moreover, specific antibody concentration
against ovalbumin significantly decreased in immunised rats
fed cocoa(15). On the other hand, a cocoa-enriched diet
reduces CD4þ T-helper (Th) lymphocyte proportion in the
spleen and mesenteric lymph nodes but its IL-2 secretion, a
cytokine with an autocrine effect producing Th proliferation,
is not modified(13).
Rheumatoid arthritis is an inflammatory autoimmune dis-
ease mainly mediated by Th cells
(16). Adjuvant arthritis (AA)
is an experimental model in rats of human rheumatoid arthritis
that has been widely used for the screening of anti-inflamma-
tory drugs(17,18). The pathogenesis of the adjuvant arthritic
process seems to be mainly related to CD4þ T-cells, because
administration of monoclonal antibodies (mAb) against CD4
can prevent AA development(19) and also ameliorate esta-
blished AA(20).
Inflammation is a complex biological response by vascular
tissues to harmful stimuli to remove the injurious agent,
as well as to initiate the tissue reparation process(21). Studies
performed in vitro have shown the anti-inflammatory proper-
ties of isolated flavonoids. In this sense, epicatechin and
isoquercitrin decrease TNF-a and monocyte chemoattractant
protein-1 production by lipopolysaccharide-stimulated macro-
phages(22). Furthermore, quercetin inhibits cyclo-oxygenase
pathways and PGE2 synthesis in the Chang liver cell line
(23)
and in human lymphocytes(24). In addition, some studies
have reasserted the anti-inflammatory capacity of isolated
flavonoids in vivo. Subcutaneous or intravenous injections
of catechin and epicatechin produce a significant reduction
of a local acute inflammation induced in rats(25).
The effect of cocoa on the inflammatory response is more
complex than that of flavonoids because it contains a mix of
diverse compounds. There are studies about the in vitro
effect of cocoa on pro-inflammatory cytokine and chemokine
release, generating controversial results. While some cocoa
flavonoid fractions increase the production of pro-inflamma-
tory cytokines in peripheral blood mononuclear cells(26–29);
a complete cocoa extract decreases the TNF-a, monocyte
chemoattractant protein-1 and nitric oxide production
by macrophages(22). In addition, peritoneal macrophages
obtained from rats fed with cocoa for at least 1 week produce
lower amounts of TNF-a, IL-6, NO and reactive oxygen
species(13,30–32). Moreover, in previous studies(30,31), a cocoa
suspension administered by the oral route for a week decreased
the local hind-paw swelling induced by carrageenin and
bradykinin in rats and reduced TNF-a concentration in inflam-
matory exudates. How cocoa metabolites down-regulate the
inflammatory response remains to be established. Some
in vitro studies have shown that flavonoids such as epicate-
chin, catechin, dimeric procyanidins and quercetin can
modify the NF-kB pathway(33,34) involved in the synthesis of
inflammatory products.
Because cocoa inhibits the release of some inflammatory
mediators in vitro, reduces acute local inflammation in
rodent models and decreases the Th-cell proportion in several
lymphoid tissues in vivo, the aim of the present study was to
determine the effects of two cocoa-enriched diets on AA.
Specifically, we have taken into consideration not only clinical
and biochemical inflammatory indices, but also antibody




A total of forty-five 9-week-old female Wistar rats were
obtained from Harlan (Barcelona, Spain). Rats were housed
three to four per cage in controlled temperature (20 ^ 28C)
and humidity (55 %) conditions in a 12 h light–12 h dark
cycle, with free access to food and water. Handling was
done in the same time range to avoid the influence of bio-
logical rhythms. Studies were performed in accordance with
the institutional guidelines for the care and use of laboratory
animals established by the Ethical Committee for Animal
Experimentation at the University of Barcelona and approved
by the Catalonian Government.
Induction and assessment of adjuvant arthritis
To induce the arthritis process, rats were injected intrader-
mally into the base of the tail with a suspension of 0·5 mg
heat-killed Mycobacterium butyricum (Mb; Difco, Detroit,
MI, USA) in 0·1 ml of liquid vaseline. AA was clinically
assessed by means of hind-paw volume with a water
plethysmometer (LI 7500; Letica, Barcelona, Spain). Left and
right hind-paw volumes were measured just before AA induc-
tion (on day 0), daily during the second week post-induction,
and every other day until the end of the study. All deter-
minations were performed in a blinded manner. Articular
inflammation was expressed as a percentage of increase in
both hind-paw volumes with respect to their value on day 0.
On day 14, animals were classified as arthritic if the increase
in hind-paw volumes was higher than the volume increase
media of healthy animals fed a standard diet (REF) plus two
times its standard deviation.
Experimental design
The standard diet corresponded to the American Institute of
Nutrition-93M formulation, which provides the nutrients
required for optimal rat maintenance and was used as the
reference diet (Table 1). Partially defatted Natural Forastero
cocoa (Nutrexpa, Barcelona, Spain) was used to manufacture
cocoa chows. This cocoa powder contained 22 % proteins,
16 % carbohydrates, 11 % lipids and 25·5 % fibre, and 21·2 mg
of total phenols/g according to the Folin–Ciocalteu method.
Cocoa diets (5 and 10 %) were prepared partially removing
maize starch, soyabean oil, cellulose and casein from American
Institute of Nutrition-93M standard starch and adding 50 or

















100 g cocoa/kg of chow, respectively (Table 1). In conse-
quence, the resulting chow had the same proportion of
carbohydrates, lipids, proteins and total energy as the
standard diet. Following the conversion of animal doses into
human equivalent doses described by Reagan-Shaw et al.(35),
the 5 % cocoa-enriched diet was equivalent to 0·454 g
cocoa/kg human per d (27·25 g cocoa for a 60 kg individual)
and the 10 % cocoa-enriched diet was equivalent to 0·908 g
cocoa/kg human per d (54·5 g cocoa for a 60 kg individual).
Animals were randomly distributed into four different experi-
mental groups: REF (n 12); arthritic animals fed a standard diet
(REF-AA; n 11); arthritic animals fed a 5 % cocoa-enriched
diet (C5-AA; n 11); arthritic animals fed a 10 % cocoa-enriched
diet (C10-AA; n 11). The REF and REF-AA groups were
fed with the standard diet, the C5-AA group was fed with the
5 % cocoa-enriched diet and the C10-AA group with the 10 %
of cocoa-enriched diet. The diets began 14 d before arthritis
induction and lasted until the end of the study, a total of
6 weeks (Fig. 1).
At weeks 2 and 3 post-induction, the animals were anaes-
thetised by isoflurane inhalation in order to collect 100ml
of blood by tail vein puncture for serum anti-Mb antibody
determination (Fig. 1). On day 28 post-induction, the animals
were anaesthetised with ketamine (90 mg/kg; Merial, Lyon,
France) and xylazine (10 mg/kg; Bayer HealthCare, Kiel,
Germany) intraperitoneally and killed by total exsanguination
by cardiac puncture. Blood and lymphoid tissues such as
spleen, representative of the systemic immune tissues, and
inguinal lymph nodes (ILN), that drain the knee joint synovia,
one of the most affected tissues in AA, were obtained. An
aliquot of each blood sample was used to automatically
count the leucocytes by using a Coulter Counter JT
haemocytometer (Hialeah, FL, USA) calibrated for rat blood.
The differential white blood count was obtained by manual
enumeration of May–Grünwald–Giemsa-stained blood cell
smears.
Cell isolation from peripheral blood, lymph nodes and
spleen
On the day of killing, blood was immediately treated with
10 g/l NH4Cl solution to lyse erythrocytes. After washing
once with PBS containing 2 % fetal bovine serum (FBS; PAA,
Pashing, Austria) and 0·1 % NaN3, peripheral blood cells
were ready for immunofluorescence staining.
ILN and spleen were broken up by passing the tissues
through a steel mesh (Cellectore; Bellco, Vertieb, Austria)
with Roswell Park Memorial Institute-1640 media containing
10 % FBS (RPMI-FBS). Cells were then centrifuged (540g,
10 min, 48C) and resuspended in PBS. Then, lymphocytes
from ILN were ready for immunofluorescence staining. The
spleen cells underwent an erythrocyte lysis by adding distilled
water for 5 s and restoring tonicity by adding PBS ten times.
Then, cells were washed and resuspended with RPMI-
FBS containing 100 000 U/l penicillin and 0·1 g/l streptomycin
2 mM-L-glutamine (Sigma Chemical Company, St Louis, MO,
USA), and 0·05 mM-2-mercaptoethanol (Merck KGaA, Darm-
stadt, Germany) to be cultured. Number and viability were
determined by acridine orange and ethidium bromide
(Sigma) staining followed by fluorescence light microscopical
analysis.
Immunofluorescence staining and flow cytometry analysis
Lymphocyte phenotype was determined just after cell isolation
by double or triple staining, using fluorochrome-conjugated
mAb followed by flow cytometry analysis. Mouse anti-rat
mAb conjugated to fluorescein isothiocyanate, phycoerythrin,
peridinin chlorophyll protein or allophycocyanin used here
included the following: anti-T-cell receptor (TCR) ab (R73),
anti-TCRgd (V65), anti-NKR-P1A (10/78), anti-CD4 (OX-35),
anti-CD25 (IL-2Ra chain, OX-39), anti-CD8a (OX-8), anti-











Casein 140 129 118
L-Cys 1·8 1·8 1·8
Maize starch 465·69 457·69 449·69
Maltodextrin 155 155 155
Sucrose 100 100 100
Soyabean oil 40 34·5 29
Cellulose 50 37·25 24·5
Mineral mix (TD94046) 35 35 35
Vitamin mix (TD94047) 10 10 10
Choline bitartrate 2·5 2·5 2·5
tert-Butylhydroquinone 0·008 0·008 0·008
Natural cocoa powder – 50 100
Total energy (kJ/kg diet) 15 069·6 15 069·6 15 069·6
AIN, American Institute of Nutrition.
* The cocoa powder used contained 22 % proteins, 16 % carbohydrates, 11 % lipids
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Fig. 1. Diagram of the experimental design beginning 14 d before adjuvant arthritis (AA) induction until day 28 post-induction. ILN, inguinal lymph node.

















CD45RA (OX-33), anti-CD81 (Eat2) (BD Biosciences, Erembo-
degem, Belgium) and anti-Foxp3 (FJK-16a; eBioscience,
Frankfurt, Germany). Extracellular staining was performed in
5 £ 105 cells by saturating concentrations of fluorochrome-
mAb in PBS containing 1 % FBS and 0·1 % NaN3 (30 min,
48C, in the dark). A negative control staining using an
isotype-matched mAb was included for each sample. For intra-
cellular staining, cells previously labelled with anti-CD4-
phycoerythrin and anti-CD25-fluorescein isothiocyanate
mAb were treated with a Foxp3 fixation/permeabilisation kit
(eBioscience). Then, intracellular staining with anti-Foxp3-APC
mAb was carried out in the same conditions as extracellular
staining. All stained cells were fixed with 0·5% p-formaldehyde
and stored at 48C in the dark. Analysis was performed using
a Cytomics FC500-MPL cytometer (Beckman Coulter, Miami,
FL, USA).
Lymphocyte subsets were defined in the cytometer
as follows: Tab (TCRabþ NKR-P1A2), Tgd (CD8þ TCRgdþ),
B (CD45RAþ), natural killer (NK; NKR-P1Aþ TCR-ab2),
natural killer T (NKT; NKR-P1Aþ TCRabþ), Th (CD4
þ
TCRabþ), T-cytotoxic (Tc; TCRab
þ CD8aþ NKR-P1A2), Th2
(CD4þ TCRabþ CD81þ), activated Th (Tact; CD4
þ CD25þ
Foxp32) and regulatory Th (Treg; CD4
þ CD25þ Foxp3þ).
Results are expressed as a percentage of positive cells in the
lymphocyte population, selected previously according to
the forward and side scatter characteristics of a cellular sus-
pension that includes positive cells stained with anti-TCR,
anti-NKR-P1A and anti-CD45RA. In some cases, results are
presented as a percentage of positive cells in a specific
lymphocyte subset (T, Th or NK cells).
Anti-Mycobacterium butyricum antibodies in serum
Anti-Mb antibody levels in sera were determined by using an
indirect ELISA technique, as described previously(36). Briefly,
polystyrene microELISA plates (Nunc Maxisorp, Wiesbaden,
Germany) were incubated with a soluble protein fraction of
Mb in PBS (3mg/ml). After sample incubation, peroxidase-
conjugated goat anti-rat Ig antibodies (BD Biosciences) were
used. Since standards were not available, several dilutions of
pooled sera from REF-AA animals were added to each plate.
This pool was arbitrarily assigned 64 000 U/l anti-Mb
antibodies.
Spleen cell culture and cytokines and PGE2 secretion
Splenocytes were cultured at 3 £ 106 cells/ml in twenty-
four-well plates. Cells were stimulated with Mb (10mg/ml)
for 24, 48 or 72 h or remained without a stimulus. IL-2 concen-
tration was quantified in the 24 h supernatant using a rat ELISA
set (BD Biosciences). Interferon g (IFN-g) concentration was
determined in the 72 h supernatant with a Biosource ELISA
set (Nivelles, Belgium). PGE2 concentration was determined
in the 48 h supernatant by a competitive immunoassay kit
from Cayman Chemicals (Ann Arbor, MI, USA) according
to the manufacturers’ recommendations. The time points to
perform these analyses were established in a preliminary
study by determining the maximal concentrations of these
analytes in our culture conditions.
Statistics
The software package SPSS 16.0 (SPSS, Inc., Chicago, IL, USA)
was used for statistical analysis. Levene’s and Kolmogorov–
Smirnov’s tests were applied to assay variance equality and
normal distribution of the studied groups, respectively. The
one-way ANOVA followed by Scheffé’s post hoc significance
test was applied when the assumptions of normality and
equal variance were met. In the opposite case, non-parametric
tests (Kruskal–Wallis and Mann–Whitney U) were used to
assay significance. Significant differences were accepted
when P,0·05.
Results
Effect of the cocoa diet on body weight and articular
inflammation
At the beginning of the study, body weight was 165·2 (SEM
1·1) g for all the studied groups. After 6 weeks of the diet,
body weight was 231·8 (SEM 3·6) g for the REF group, 200·2
(SEM 5·4) g for the REF-AA group, 198·9 (SEM 2·4) g for the
C5-AA group and 192·9 (SEM 4·0) g for the C10-AA group.
Therefore, regardless of the diet, at day 28 post-induction,
all AA animals presented similar body weight, which was
lower than that of healthy animals (P,0·05).
On day 14 post-induction, arthritis incidence was over
92 % for the reference arthritic group (REF-AA), similar to
that found in both cocoa-fed groups (C5-AA and C10-AA).
The time course of hind-paw volume increase after arthritis
induction is summarised in Fig. 2(a). Paw volume reached a
maximum increase of 130 % in the REF-AA group on day 21
post-induction. Animals from the C5-AA group displayed a
lower paw volume increase than the reference group from
day 16 to 28 post-induction, but differences were not statisti-
cally significant. On the last day of the study, the C5-AA
volume increase was reduced by 32 % of that of the REF-AA
group (Fig. 2(b)). Animals from the C10-AA group showed a
paw oedema pattern similar to the REF-AA group, but on
the last day of the study, the values were 28 % lower than
those of the REF-AA (Fig. 2(b)).
Effect of the cocoa diet on peripheral blood lymphocyte
subsets in adjuvant arthritis rats
AA induced leucocytosis due to a neutrophil increase while
the lymphocyte counts remained in the blood (Table 2).
Alterations induced by AA were not modified by the
cocoa diet.
Percentages of blood Tab, Tgd, B, and NK lymphocytes
did not change significantly in the REF-AA group (Fig. 3(a)).
In the case of arthritic rats, all groups showed lower blood
NKT cell percentages than the reference healthy animals
(REF). Moreover, the blood Tab cell percentage in animals

















fed a 10 % cocoa-enriched diet decreased with respect to the
REF-AA group (P,0·05).
With regard to T-cell subsets (Fig. 3(b)), AA increased the
Th-cell proportion (P,0·05) and decreased the Tc-cell per-
centage (P,0·05), resulting in a higher Th:Tc ratio in REF-AA
animals compared with the REF group. Animals fed a 10 %
cocoa-enriched diet avoided this Th:Tc imbalance caused by
the arthritic process (P,0·05 v. REF-AA). The Th:Tc ratio in
rats from the 5 % cocoa diet group remained similar to that
of REF animals, although values were not statistically different
from the REF-AA group.
The proportion of Th2 cells was assessed by means of the
presence of CD81 in Th cells. As shown in Fig. 3(c), the
arthritic process did not affect the proportion of these cells,
but both cocoa diets tended to reduce the Th2 proportion.
Moreover, the AA process reduced the Treg (CD4
þ CD25þ
Foxp3þ) cell proportion with respect to the REF group
(P,0·05; Fig. 3(c)) and, interestingly, the 10 % cocoa-enriched
diet avoided this alteration. Tact cell proportion, determined
as CD4þ CD25þ Foxp32 lymphocytes, was not affected by
AA or the cocoa diets. NK cell subsets determined by CD8
phenotype (Fig. 3(d)) were not modified either by the AA
process or cocoa intake.
Effect of the cocoa diet on inguinal lymph node
lymphocyte subsets in adjuvant arthritis rats
The study of the main lymphocyte populations in ILN
(Fig. 4(a)) revealed almost no changes induced by the arthritic
process, as seen in the REF-AA group. There was only an
increase in the low percentage of NKT cells (P,0·05),
which was also found to a lesser degree in the C5-AA
and C10-AA groups. The cocoa diets decreased the B-cell
population in AA rats in comparison with the REF group
(P,0·05; Fig. 4(a)), and there was a concomitant increase in
Tab cells in the C5-AA group.
Although the arthritic process did not modify the proportion
of Th and Tc cells, both cocoa diets produced a decrease in the
Th-cell proportion in ILN (P,0·05; Fig. 4(b)).
On the other hand, neither arthritis nor the cocoa diets
changed the Th2 cell profile in this tissue (Fig. 4(c)). Pro-
portion of regional Treg cell was not affected by the arthritic
process or by the cocoa diets (Fig. 4(c)). In contrast, the
proportion of Tact lymphocytes in arthritic animals increased
significantly in ILN (P,0·05).
With respect to the NK cell population (Fig. 4(d)), the arthritic
process increased more than twofold the CD8þ:CD82 ratio in
NK cells (P,0·05). The cocoa diets avoided this marked



































































Fig. 2. Effect of cocoa diets on the clinical evolution of adjuvant arthritis (AA) evaluated by hind-paw volume increase, measured by a water plethysmometer.
(a) Time course of AA (expressed as a percentage of increase in both hind-paw volumes with respect to their value on day 0): , healthy animals fed a stan-
dard diet (REF); , arthritic animals fed a standard diet (REF-AA); , arthritic animals fed a 5 % cocoa-enriched diet (C5-AA); , arthritic animals fed
a 10 % cocoa-enriched diet (C10-AA). (b) Percentage of hind-paw volume increase on the last day of the study. Values are means, with their standard errors
represented by vertical bars (n 11–12). * Mean values were significantly different from those of the REF group (P,0·05; ANOVA followed by Scheffé’s test).
Table 2. Effect of adjuvant arthritis and cocoa diets on blood leucocyte,
lymphocyte and neutrophil counts












Mean SEM Mean SEM Mean SEM
REF (n 12) 2·81 0·63 2·24 0·63 0·46 0·08
REF-AA (n 11) 5·81* 0·95 2·69 0·48 2·76* 0·50
C5-AA (n 11) 5·88* 0·87 2·65 0·51 2·87** 0·48
C10-AA (n 11) 5·06 1·00 2·11 0·56 2·72* 0·50
REF, healthy animals fed a standard diet; REF-AA, arthritic animals fed a standard
diet; C5-AA, arthritic animals fed a 5 % cocoa-enriched diet; C10-AA, arthritic
animals fed a 10 % cocoa-enriched diet.
Mean values were significantly different from those of the REF group (one-way
ANOVA followed by Scheffé’s test): *P,0·05, **P,0·001.

















Effect of the cocoa diet on anti-Mycobacterium butyricum
antibodies in adjuvant arthritis rats
Arthritis induction, by means of heat-killed Mb, involved the
synthesis of antibodies directed against mycobacteria (Fig. 5),
which are absent in non-induced animals (data not shown).
The serum concentration of these antibodies increased
during the arthritis time course. The intake of both cocoa
diets (5 and 10 %) reduced serum anti-Mb antibody synthesis,
an effect that was already detected at 2 weeks after induction
(P,0·05). This inhibition was dose-dependent and continued
until the end of the study.
Effect of the cocoa diet on ex vivo cytokine and PGE2
secretion by splenocytes
Splenocytes obtained on day 28 post-induction from animals
of all the induced groups produced IL-2 and IFN-g after the
Mb challenge (Fig. 6(a) and (b)). IL-2 secretion was higher
in splenocytes from the C5-AA and C10-AA groups than
those from the REF-AA group (P,0·05; Fig. 6(a)). However,
cocoa did not affect IFN-g secretion, which was similar in all
three AA groups (Fig. 6(b)).
PGE2 was secreted by splenocytes (Fig. 6(c)) from healthy
and arthritic animals either without stimulus or after Mb
addition. In non-stimulated conditions, PGE2 released by cells
obtained from the C10-AA group was significantly lower than
that from the REF and REF-AA groups (P,0·05). However,
no significant changes were observed in Mb-stimulated cells.
Discussion
In previous studies, cocoa has shown anti-inflammatory
properties both in vitro and in vivo (22,31). We have previously
demonstrated that cocoa-enriched diets in young and adult
animals modulate the synthesis of total and specific anti-
bodies(13,15) and also decrease the proportion of Th cells
in several lymphoid compartments(14) in healthy conditions.
On the other hand, some studies have reported the protective
effect of flavonoids on arthritis models(37–39), and specifically
on adjuvant-carrageenin-induced arthritis in rats(40,41). All these
results prompted us to study the influence of long-term cocoa
diets with two different dosages in a T-cell-mediated systemic
inflammation model, as in AA(19), a well-established severe
polyarthritis chronic model that lasts at least 3 months(42).
The present study shows that a cocoa-enriched diet was
able to decrease the synthesis of antibodies against the pathol-
ogy inducer during the progression of AA. The cocoa diet was
also able to decrease the proportion of Th lymphocytes in
blood and regional lymphoid tissues, which probably include
cells responsible for the arthritic process. Moreover, the cocoa
diet showed a tendency to modulate hind-paw swelling. The
clinical evolution of AA in animals fed a 5 % cocoa-enriched
diet had a tendency to reduce the severity of the process,
but unfortunately, a significant diminution of the arthritic pro-
cess was not achieved through the cocoa diets. These results
are in contrast with those of Pelzer and co-workers(40,41),















































































































Tαβ Tγδ B NK NKT
* * *
Fig. 3. Lymphocyte subset composition in rat blood, determined by double
or triple staining, using fluorochrome-conjugated monoclonal antibodies
followed by flow cytometry analysis. (a) Tab, Tgd, B, natural killer (NK) and
natural killer T (NKT) lymphocyte percentages. (b) T-helper (Th) and T-cyto-
toxic (Tc) cell percentages in the T-cell population and Th:Tc ratio. (c) Th2,
activated Th (Tact) and regulatory Th (Treg) percentages in the Th subset.
(d) CD8þ and CD82 cell percentages in NK lymphocytes. Values are means,
with their standard errors represented by vertical bars (n 9–12, with the
exception of B-cells n 5–9). * Mean values were significantly different from
those of healthy animals fed a standard diet (REF, ) (P,0·05). † Mean
values were significantly different from those of arthritic animals fed
a standard diet (REF-AA, ) (P,0·05; Kruskal–Wallis and Mann–Whitney
U tests). C5-AA, arthritic animals fed a 5 % cocoa-enriched diet ( ); C10-AA,
arthritic animals fed a 10 % cocoa-enriched diet ( ).

















model. However, these studies were performed by using
single flavonoids (quercetin, rutin, hesperidin and morin)
administered intraperitoneally, and the AA model was induced
through a rather different procedure. In addition, some of
these flavonoids, such as hesperidin, morin and rutin, are
not even present in cocoa, and there are controversial results
about the anti-inflammatory capacity of hesperidin(43). Our
results do not agree with another study that used quercetin
administered orally in a rat AA model(44). Nevertheless,
the quercetin dosage used in that study was very high
(150 mg/rat), while the quercetin concentration in a cocoa
extract is just over 57mg/g(45). The lack of a clear effect in
the present study could then be explained by the low pro-
portion of quercetin in cocoa flavonoids(45) and the daily
intake of cocoa that was about 600 mg/100 g of rat(15). In
fact, the main and best-absorbed flavonoid in cocoa is epica-
techin(4), a flavonoid with ascribed anti-inflammatory activities
in vitro (22,33).
Previous studies(13,14) performed on young healthy rats
showed that a 10 % cocoa-enriched diet produced a decrease
in Th proportion in the spleen and lymph nodes. Here, we
have also showed that a cocoa diet reduces the Th proportion
in the blood and ILN in AA rats. In consequence, it could be
suggested that cocoa intake could entail reduction in the
number of Th cells involved in the arthritic process
(20). How-
ever, this effect may not be enough to abolish the activity of
pathogenic cells. This suggestion is in line with the concen-
tration of IFN-g, a pro-inflammatory cytokine, released from
the splenocyte supernatants, which were similar in the three
arthritic groups. IFN-g is a cytokine mainly produced by Tact
cells that enhances the inflammatory process through macro-
phage activation(46).
The effect of a cocoa diet on Treg cells is also of interest
because these cells regulate immune responses(47), and there
is some evidence that patients with rheumatoid arthritis have
defective Treg cell function
(48). It has been recently reported



















































































































Fig. 4. Lymphocyte subset composition in rat inguinal lymph nodes, deter-
mined by double or triple staining, using fluorochrome-conjugated mono-
clonal antibodies followed by flow cytometry analysis. (a) Tab, Tgd, B,
natural killer (NK) and natural killer T (NKT) lymphocyte percentages. (b) T-
helper (Th) and T-cytotoxic (Tc) cell percentages in the T-cell population.
(c) Th2, activated Th (Tact) and regulatory Th (Treg) percentages in the Th sub-
set. (d) CD8þ and CD82 cell percentages in NK lymphocytes. Values are
means, with their standard errors represented by vertical bars (n 9–12).
* Mean values were significantly different from those of healthy animals fed a
standard diet (REF, ) (P,0·05). † Mean values were significantly different
from those of arthritic animals fed a standard diet (REF-AA, ) (P,0·05;
Kruskal–Wallis and Mann–Whitney U tests). C5-AA, arthritic animals fed a
5 % cocoa-enriched diet ( ); C10-AA, arthritic animals fed a 10 % cocoa-

































Fig. 5. Anti-Mycobacterium butyricum (Mb) antibody concentration in serum
during arthritis time course. Values are means, with their standard errors
represented by vertical bars (n 11–12). † Mean values were significantly
different from those of arthritic animals fed a standard diet (REF-AA, )
(P,0·05; Kruskal–Wallis and Mann–Whitney U tests). C5-AA, arthritic
animals fed a 5 % cocoa-enriched diet ( ); C10-AA, arthritic animals fed a
10 % cocoa-enriched diet ( ).

















collagen-induced arthritis significantly prevented the disease
development(49) and also slowed the arthritic progression(50).
In the present study, AA reduced the proportion of the Treg
population in blood, but not in ILN. Interestingly, preventive
consumption of a 10 % cocoa-enriched diet avoided the Treg
decrease, keeping it in the healthy proportion. The increase
in the Treg subset proportion in the C10-AA group could be
due to an increase in IL-2 synthesis, because it has been
reported that IL-2 favours Treg production
(51). In the present
study, an IL-2 increase was observed in splenocytes from
cocoa-fed rats. In any case, the enhancement of Treg induced
in 10 % cocoa-fed animals was not reflected by a decrease in
Tact lymphocytes, and these changes were only present in
blood and not in ILN.
Another result that deserves attention is the effect of the
cocoa diet on NK and NKT cells. NKT cells are immunoregu-
latory T lymphocytes that can promote cell-mediated immu-
nity against tumours and infectious organisms but can also
suppress the cell-mediated immunity associated with allograft
rejection and autoimmune disease(52). In the present study, AA
increased the NKT cell percentage in ILN, and decreased that
in blood. With respect to NK cells, previous studies have
determined that CD8þ NK cells are more cytolytic than
CD82 NK cells and this molecule helps NK cells to survive
after target cell lysis(53). In the present study, the NK
CD8þ:CD82 ratio was increased in ILN from AA animals,
suggesting an activation of cytolytic function in these cells
by the inflammatory process. A cocoa diet prevented this dis-
equilibrium in regional lymph nodes but this effect was not
significantly reflected in articular swelling. Nevertheless, it
would be interesting to understand the role of NKT and NK
cells in the AA model.
Although AA is ascribed to the cellular response(54),
antibodies against the mycobacteria were developed(55).
Cocoa-enriched diets were able to decrease the levels of
anti-Mb antibodies in a similar way as observed in another
approach(15). The role of anti-Mb antibodies in the develop-
ment of hind-paw swelling is negligible but a role in the late
phase of arthritis has been suggested(55). From the present
results, it is clear that the reduction of the antibody proportion
through cocoa intake was not enough to regulate the arthritic
process during the first weeks (when articular inflammation
increased), but it could explain the modulation of arthritic
swelling at the 4th week. It is possible that cocoa accelerated
the recuperation of this pathology by decreasing the anti-Mb
antibody levels. In any case, the down-regulatory effects
of antibodies due to cocoa intake could be more significant
in autoimmune arthritis, both in experimental models
(collagen-induced arthritis) and in human disease.
With respect to PGE2 release, an increase in its concen-
tration has been reported in the urine of AA rats(56), just
as in human rheumatoid arthritis synovial(57). Here, we show
that a cocoa diet reduced splenocyte PGE2 production in
the C10-AA group. As macrophage is the main source of
PGE2 during inflammation
(58), the PGE2 reduction found
here correlates with previous results, showing that peritoneal
macrophages from animals fed cocoa produced lower
amounts of other pro-inflammatory mediators such as IL-6,
TNF-a and NO ex vivo (31,32).
From the results obtained in the present study, it can be
concluded that cocoa intake reduces the Th-cell proportion
and modulates some alterations induced by the arthritic pro-
cess, such as a decrease in the blood Treg cell percentage
and a disequilibrium in inguinal NK cells. Moreover, a cocoa
diet reduces the anti-Mb antibody concentration in sera and
diminishes spleen PGE2 production. These changes are not
enough to significantly decrease chronic articular swelling,
although a tendency to its modulation is observed at the
end of the study. Finally, we can conclude that a cocoa diet
channels the organism to develop an ‘anti-inflammatory
environment’. Other studies need to be performed in order
to establish the effect of cocoa in autoimmune arthritic
models and its potential as an accompaniment of anti-inflam-
matory drugs.
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Fig. 6. Inflammatory mediator concentrations in spleen cell supernatants. (a) IL-2 concentration in the 24 h spleen supernatant. (b) Interferon g (IFN-g) concen-
tration in the 72 h spleen supernatant. (c) PGE2 concentration in the 48 h spleen supernatant. Values are means, with their standard errors represented by
vertical bars (n 10–12). * Mean values were significantly different from those of healthy animals fed a standard diet (REF, ) (P,0·05). † Mean values were
significantly different from those of arthritic animals fed a standard diet (REF-AA, ) (P,0·05; Kruskal–Wallis and Mann–Whitney U tests). NS, non-stimulated;
Mb, Mycobacterium butyricum stimulated; C5-AA, arthritic animals fed a 5 % cocoa-enriched diet ( ); C10-AA, arthritic animals fed a 10 % cocoa-enriched diet ( ).

















the statistical analysis and drafted the manuscript. F. J. P.-C.
and C. C. collaborated during the in vivo part and in
the discussion of the results. M. C. and A. F. designed, super-
vised and coordinated the study. All the authors read and
approved the final manuscript. The authors would like to
thank the ‘Serveis Cientı́fico-Tècnics’ of the University of
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